Tango Therapeutics TNGX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's total liabilities?
- Tango Therapeutics (TNGX) reported total liabilities of $44.29M in Q1 2026.
- How has Tango Therapeutics's total liabilities changed year-over-year?
- Tango Therapeutics's total liabilities decreased by 58.8% year-over-year, from $107.55M to $44.29M.
- What is the long-term trend for Tango Therapeutics's total liabilities?
- Over 5 years (2020 to 2025), Tango Therapeutics's total liabilities has grown at a -20.8% compound annual growth rate (CAGR), from $168.65M to $52.51M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.